S32 Evaluating the Effectiveness of Subcutaneous Ustekinumab Induction in Inflammatory Bowel Disease: Insights From Real-World Evidence
Year: 2024
Type: conference-abstract
Institution: Hospital General de México
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4405168609
